Baxter Announces Strategic Actions to Enhance Operational …
Jan 6, 2023 · Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders.
Baxter Newsroom
We invite you to read the latest news about our initiatives and innovations, and follow us on our corporate social media channels to receive timely updates.
Baxter Announces Definitive Agreement to Divest Its Vantive …
Aug 13, 2024 · Baxter and Carlyle have signed a definitive agreement to divest Baxter's Kidney Care segment, to be named Vantive, in late 2024 or early 2025. Vantive is a global leader in kidney care and vital organ therapies, offering products and …
Baxter - Baxter to Acquire Hillrom, Expanding Connected Care and ...
Sep 2, 2021 · Baxter, a global medical products company, and Hillrom, a medical technology leader, announced a definitive agreement to merge for $10.5 billion. The transaction will create a broader array of medical products and services across the care continuum and accelerate digital and connected care solutions.
Baxter Reports First-Quarter 2024 Results
May 2, 2024 · Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2024.
Baxter - Baxter Provides Update on North Cove, N.C., Facility and ...
Sep 29, 2024 · Baxter's North Cove facility in Marion, N.C., which produces intravenous and peritoneal dialysis solutions, was closed by flooding due to Hurricane Helene in September 2024. The company is working to resume production and mitigate supply disruption to patients, while also supporting recovery efforts in the community.
Baxter Signs Definitive Agreement to Divest its BioPharma …
May 8, 2023 · Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced that it has signed a definitive agreement to divest its BioPharma Solutions (“BPS”) business to Advent International (“Advent”), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth ...
Baxter Reports Fourth-Quarter and Full-Year 2023 Results
Feb 8, 2024 · Baxter, a global medtech leader, reported sales growth of 3% on a constant currency basis for full-year 2023, driven by strong performance in Healthcare Systems and Technologies and Medical Products and Therapies segments. The company also provided its financial guidance for full-year and first-quarter 2024, and announced its proposed separation of Kidney Care segment.
Baxter Provides Update on North Cove, N.C., Facility and Hurricane ...
Sep 29, 2024 · Baxter, a global medtech leader, provides an update on the impact of Hurricane Helene on its North Cove site in Marion, N.C., which produces intravenous and peritoneal dialysis solutions. The company is working to resume production, support customers and communities, and assess the financial impact of the storm.
Baxter - Baxter Highlights Business Strategies and Innovation at …
May 25, 2022 · Baxter expects constant currency sales growth of 4% to 5% on a compounded annual basis from 2022 through 2025. The company expects 2025 adjusted operating margin to expand by 350 to 400 basis points as compared to expected year-end 2022. Baxter anticipates free cash flow conversion of more than 80% by 2025.